GENE ONLINE|News &
Opinion
Blog

2022-05-24| Trending

Global Race to Track and Contain Monkeypox Outbreak

by Fujie Tham
Share To

Sudden emergence of monkeypox cases in several countries spanning multiple continents has raised questions about how the virus, common in west and central Africa, managed to spread. Facing these surprise transmissions, the Belgian government issued mandatory 21-day isolation for monkeypox cases, and the UK Health Security Agency has also updated its guidance advising close contacts to isolate for 21 days.

First discovered in 1958, the monkeypox virus (MPV or MPXV) belongs to the Orthopoxvirus genus, it is a double-stranded DNA zoonotic virus that causes monkeypox in humans and animals, the usual symptoms are rash and fever. The Orthopoxvirus genus also includes variola virus (smallpox), vaccinia virus (used in the smallpox vaccine), and cowpox virus.

Monkeypox Virus Sample (US CDC 2022)
Monkeypox Virus Sample (US CDC 2022)

Infections usually occur outside of west and central parts of Africa when a person becomes infected locally and then returns home, bringing the virus with them; these cases normally do not cause larger outbreaks. However, this new wave of infections predominantly with no link to travel or animals across Europe, North America, and Australia has prompted the World Health Organization (WHO) to expand surveillance to non-endemic regions and expects more cases to be identified.

Monkeypox endemic countries are: Benin, Cameroon, the Central African Republic, the Democratic Republic of the Congo, Gabon, Ghana (animals only), Ivory Coast, Liberia, Nigeria, the Republic of the Congo, Sierra Leone, and South Sudan.

Related article: Convergence, Communication and Commercialization, The Cornerstones In Emerging Regulatory Trends

 

Cases Have Been Rising, but Low Risk to Population 

 

Despite being the largest outbreak outside of Africa in the past five decades, monkeypox does not spread easily between people. The WHO and health bodies such as the US CDC say that the threat to the general public is low and not comparable to the COVID-19 pandemic.

According to the CDC, human-to-human transmission mainly occurs via large respiratory droplets. “Respiratory droplets generally cannot travel more than a few feet, so prolonged face-to-face contact is required,” the CDC says. Other transmission means include direct contact with bodily fluids or indirect contact with lesion material-contaminated clothing. WHO shared that recent infections appear to have been spread through sex.

Vaccines are now offered to high-risk healthcare providers but are not widely available yet. Recently, Bavarian Nordic A/S announced that it is ramping up Jynneos (Imvanex in Europe; Imvamune in Canada) production following the outbreak. Studies showed that the Jynneos smallpox vaccine is about 85% effective in preventing monkeypox, while immunization after monkeypox exposure may also prevent the disease or reduce its severity.

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
Arab Health Congress Confirms Partnership with Dubai Health Authority
2024-01-12
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top